These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11412731)

  • 1. [Use of aprotinin during pediatric heart surgery].
    Martín Burcio S; Valiño González J; Domínguez F; Díaz Balda J; Martínez M; Vellibre D
    Rev Esp Anestesiol Reanim; 2001 May; 48(5):212-6. PubMed ID: 11412731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aprotinin reduces homologous blood transfusions when pediatric cardiac surgery must be redone].
    Ohuchi H; Okabe H; Nagata N; Kaneko Y
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):1980-5. PubMed ID: 8958711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only.
    Carrel TP; Schwanda M; Vogt PR; Turina MI
    Ann Thorac Surg; 1998 Jul; 66(1):153-8. PubMed ID: 9692456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
    Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
    Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience.
    Fan Y; Lin R; Yang L; Ye L; Yu J; Shu Q
    Paediatr Anaesth; 2013 Mar; 23(3):242-9. PubMed ID: 23189963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery.
    Oliver WC; Fass DN; Nuttall GA; Dearani JA; Schrader LM; Schroeder DR; Ereth MH; Puga FJ
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1670-7. PubMed ID: 15173722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study.
    Bedirhan MA; Turna A; Yagan N; Taşçi O
    Eur J Cardiothorac Surg; 2001 Dec; 20(6):1122-7. PubMed ID: 11717015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.
    Hardy JF; Desroches J; Belisle S; Perrault J; Carrier M; Robitaille D
    Can J Anaesth; 1993 Jul; 40(7):625-31. PubMed ID: 7691426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations.
    Ciçek S; Demirkiliç U; Kuralay E; Ozal E; Tatar H
    Ann Thorac Surg; 1996 May; 61(5):1372-6. PubMed ID: 8633944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative use of aprotinin in cardiac operations: an alternative to its prophylactic use.
    Ciçek S; Demirkiliç U; Ozal E; Kuralay E; Bingol H; Tatar H; Ozturk OY
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1462-7. PubMed ID: 8975837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
    Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
    Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study.
    Casas JI; Zuazu-Jausoro I; Mateo J; Oliver A; Litvan H; Muñiz-Díaz E; Arís A; Caralps JM; Fontcuberta J
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1107-17. PubMed ID: 7475139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
    Mössinger H; Dietrich W
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin and transfusion requirements in pediatric craniofacial surgery.
    Ahmed Z; Stricker L; Rozzelle A; Zestos M
    Paediatr Anaesth; 2014 Feb; 24(2):141-5. PubMed ID: 24138460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.